Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Tirzepatide is a dual GIP and GLP-1 receptor agonist a class of medication that mimics two naturally occurring gut hormones involved in appetite regulation and blood sugar control
Tirzepatide is a dual agonist that combines: GLP-1 (glucagon-like peptide-1) activity GIP (glucose-dependent insulinotropic polypeptide) activity This combination creates a stronger incretin effect, improving insulin sensitivity and appetite control more effectively than GLP-1 medications alone
It can also inhibit the proliferation of colon cancer cells and induce their apoptosis by inhibiting the synthesis of GSK3 (47)
For women, this floor should be 1,200 calories
58 HebertG.ArsautJ.DantzerR.Demotes-MainardJ
Valdecantos P, Rada P, Ghosh S, Rondinone CM, Valverde AM
-the-right-way-seo-graphics-gs.png?sfvrsn=5784682_3)
US$ 24.07
US$ 27.55
US$ 25.87
